MENU
+Compare
STRO
Stock ticker: NASDAQ
AS OF
Jun 27, 03:24 PM (EDT)
Price
$0.76
Change
-$0.04 (-5.00%)
Capitalization
67.48M

STRO Sutro Biopharma Forecast, Technical & Fundamental Analysis

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company... Show more

STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for STRO with price predictions
Jun 26, 2025

STRO in upward trend: price may jump up because it broke its lower Bollinger Band on June 05, 2025

STRO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where STRO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STRO advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on STRO as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for STRO turned negative on June 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

STRO moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for STRO crossed bearishly below the 50-day moving average on June 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STRO entered a downward trend on June 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.785) is normal, around the industry mean (16.566). P/E Ratio (0.000) is within average values for comparable stocks, (58.942). STRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.298). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.989) is also within normal values, averaging (254.026).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STRO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

STRO is expected to report earnings to fall 53.58% to -42 cents per share on August 07

Sutro Biopharma STRO Stock Earnings Reports
Q2'25
Est.
$-0.42
Q1'25
Missed
by $0.06
Q4'24
Est.
$-0.83
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.20
The last earnings report on May 09 showed earnings per share of -91 cents, missing the estimate of -85 cents. With 155.19K shares outstanding, the current market capitalization sits at 67.48M.
A.I. Advisor
published General Information

General Information

a developer of new products in protein vaccines and therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
111 Oyster Point Boulevard
Phone
+1 650 881-6500
Employees
324
Web
https://www.sutrobio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY0.720.03
+4.80%
Oncolytics Biotech
RMR16.640.16
+0.97%
RMR Group (The)
CNXN65.840.03
+0.05%
PC Connection
JNJ152.01-0.27
-0.18%
Johnson & Johnson
FCN160.11-1.56
-0.96%
FTI Consulting

STRO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with ALGS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-0.78%
ALGS - STRO
44%
Loosely correlated
-6.42%
TCRX - STRO
40%
Loosely correlated
-11.90%
TRDA - STRO
40%
Loosely correlated
-0.57%
ATXS - STRO
40%
Loosely correlated
-3.72%
BEAM - STRO
38%
Loosely correlated
+2.27%
More